Kenneth S. Ogueri

Kenneth S. Ogueri

Auto-generated profile, based on publicly available information

Kenneth S. Ogueri

Connecticut Convergence Institute for Translation in Regenerative Engineering, Farmington, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2018 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
KOKenneth S. Ogueri
Kenneth S. Ogueri
TJTahereh Jafari
Tahereh Jafari
JIJorge L. Escobar Ivirico
Jorge L. Escobar Ivirico
CLCato T. Laurencin
Cato T. Laurencin

22 July 2020 in ACS Nano
Verified
Journal Article
Closed access
KOKenneth S. Ogueri
Kenneth S. Ogueri
CLCato T. Laurencin
Cato T. Laurencin

29 July 2021 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Open access
PDF file
CUChinedu C. Ude
Chinedu C. Ude
CECaldon J. Esdaille
Caldon J. Esdaille
KOKenneth S. Ogueri
Kenneth S. Ogueri
HKHo-Man Kan
Ho-Man Kan
SLSamuel J. Laurencin
Samuel J. Laurencin
CLCato T. Laurencin
Cato T. Laurencin
Metallosis is defined as the accumulation and deposition of metallic particles secondary to abnormal wear from prosthetic implants that may be visualized as abnormal macroscopic staining of periprosthetic soft tissues. This phenomenon occurs secondary to the release of metal ions and particles from metal-on-metal hip implants in patients with end-stage osteoarthritis. Ions and particles shed from implants can lead to local inflammation of surrounding tissue and less commonly, very rare systemic manifestations may occur in various organ systems. With the incidence of total hip arthroplasty increasing as well as rates of revisions due to prosthesis failure from previous metal-on-metal implants, metallosis has become an important area of research. Bodily fluids are electrochemically active and react with biomedical implants. Particles, especially cobalt and chromium, are released from implants as they abrade against one another into the surrounding tissues. The body’s normal defense mechanism becomes activated, which can elicit a cascade of events, leading to inflammation of the immediate surrounding tissues and eventually implant failure. In this review, various mechanisms of metallosis are explored. Focus was placed on the atomic and molecular makeup of medical implants, the component/surgical associated factors, cellular responses, wear, tribocorrosion, joint loading, and fluid pressure associated with implantation. Current treatment guidelines for failed implants include revision surgery. An alternative treatment could be chelation therapy, which may drive future studies.Lay Summary: Arthroplasty is an invasive procedure which disrupts surrounding joint tissues, and can greatly perturb the joint’s immune homeostasis. In some instances, this may pose a difficult challenge to implant integration. Particles released from implants into the surrounding joint tissues activate the body’s defense mechanism, eliciting a cascade of events, which leads to biotribocorrosion and electrochemical attacks on the implant. This process may lead to the release of even more particles. Besides, implant makeup and designs, frictions between bearing surfaces, corrosion of non-moving parts with modular junctions, surgical mistakes, patient factor, comorbidities, and loosened components can alter the expected function of implants. High accumulations of these ions and particulates result in metallosis, with accompanying adverse complications. Current recommended treatment for failed prosthesis is revision surgeries. However, chelation therapy as a prophylactic intervention may be useful in future efforts but more investigation is required.

30 January 2017 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
KOKenneth S. Ogueri
Kenneth S. Ogueri
JIJorge L. Escobar Ivirico
Jorge L. Escobar Ivirico
LNLakshmi S. Nair
Lakshmi S. Nair
HAHarry R. Allcock
Harry R. Allcock
CLCato T. Laurencin
Cato T. Laurencin

1 November 2019 in Progress in Polymer Science
Verified
Journal Article
Closed access
KOKenneth S. Ogueri
Kenneth S. Ogueri
HAHarry R. Allcock
Harry R. Allcock
CLCato T. Laurencin
Cato T. Laurencin

11 August 2021 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Open access
PDF file
CUChinedu C. Ude
Chinedu C. Ude
SSShiv Shah
Shiv Shah
KOKenneth S. Ogueri
Kenneth S. Ogueri
LNLakshmi S. Nair
Lakshmi S. Nair
CLCato T. Laurencin
Cato T. Laurencin
Purpose: The knee joint is prone to osteoarthritis (OA) due to its anatomical position, and several reports have implicated the imbalance between catabolic and anabolic processes within the joint as the main culprit, thus leading to investigations towards attenuation of these inflammatory signals for OA treatment. In this review, we have explored clinical evidence supporting the use of stromal vascular fraction (SVF), known for its anti-inflammatory characteristics for the treatment of OA.Methods: Searches were made on PubMed, PMC, and Google Scholar with the keywords “adipose fraction knee regeneration, and stromal vascular fraction knee regeneration, and limiting searches within 2017–2020.Results: Frequently found interventions include cultured adipose-derived stem cells (ADSCs), SVF, and the micronized/microfragmented adipose tissue-stromal vascular fraction (MAT-SVF). Clinical data reported that joints treated with SVF provided a better quality of life to patients. Currently, MAT-SVF obtained and administered at the point of care is approved by the Food and Drug Administration (FDA), but more studies including manufacturing validation, safety, and proof of pharmacological activity are needed for SVF. The mechanism of action of MAT-SVF is also not fully understood. However, the current hypothesis indicates a direct adherence and integration with the degenerative host tissue, and/or trophic effects resulting from the secretome of constituent cells.Conclusion: Our review of the literature on stromal vascular fraction and related therapy use has found evidence of efficacy in results. More research and clinical patient follow-up are needed to determine the proper place of these therapies in the treatment of osteoarthritis of the knee.Lay Summary: Reports have implicated the increased inflammatory proteins within the joints as the main cause of osteoarthritis (OA). This has attracted interest towards addressing these inflammatory proteins as a way of treatment for OA. The concentrated cell-packed portion of the adipose product stromal vascular fraction (SVF) from liposuction or other methods possesses anti-inflammatory effects and has been acclaimed to heal OA. Thus, we searched for clinical evidence supporting their use, for OA treatment through examining the literature. Data from various hospitals support that joints treated with SVF provided a better quality of life to patients. Currently, there is at least one version of these products that are obtained and given back to patients during a single clinic visit, approved by the FDA.